Test Price
2,800 AED✅ Home Collection Available
DSPP Gene Dentinogenesis Imperfecta Shields Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين DSPP لعيب تَكَوُّن العاج (خلل التنسج العاجي) من النوع الثاني (شيلدز) عبر التسلسل الجيني الفائق في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / ملخص تنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM–11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in Result Interpretation by DHA‑Licensed Experts.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة من ISO 9001:2015.
الخدمات اللوجستية المتميزة: جمع عينات منزلية بمستوى المستشفيات عبر نظام سلسلة التبريد المعتمد من ISO وخدمة الفصد المتنقلة VIP (من 8 صباحاً إلى 11 مساءً).
التوجيه السريري: إرشادات سريرية بعد الاختبار عبر الهاتف لتفسير النتائج بواسطة خبراء مرخصين من هيئة الصحة بدبي.
التأمين: التحقق المباشر من الفواتير عبر واتساب +971 54 548 8731.
Overview / نظرة عامة
The DSPP Gene Genetic Test detects pathogenic variants in the DSPP gene associated with dentinogenesis imperfecta Shields type 2, aiding in definitive diagnosis and genetic counselling. يساعد اختبار الحمض النووي بتحليل جين DSPP باستخدام تقنية تسلسل الجيل التالي في الكشف عن المتغيرات المسببة للأمراض المرتبطة بعيب تكون العاج من النوع الثاني (شيلدز) لتأكيد التشخيص والاستشارة الوراثية.
| Feature | Our Test (Premium Panel) | Standard Alternative (Targeted Sanger) |
|---|---|---|
| Methodology | NGS (Next‑Generation Sequencing) – comprehensive full‑gene analysis | Sanger sequencing of selected hotspots only |
| Diagnostic Sensitivity | 99.9% (includes deep intronic and copy‑number variants) | <95% – may miss rare or novel variants |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
| Clinical Support | Post‑test telephone guidance with DHA‑licensed genetic counsellor | Written report only |
| Price | 2800 AED | 2500 – 3500 AED (variable) |
Test Identification
- Normalized Name: DSPP Gene Dentinogenesis Imperfecta Shields Type 2 Genetic Test
- Methodology: NGS (Next‑Generation Sequencing)
- 2026 ICD‑10‑CM Codes: K00.5 (Dentinogenesis imperfecta), Z13.71 (Encounter for genetic screening), Z15.89 (Genetic susceptibility to other disease)
- LOINC Code: 93382‑9 – DSPP gene full mutation analysis in Blood or Tissue by Sequencing
Sample & TAT
- Accepted Samples: Whole Blood (EDTA), Extracted DNA, or One drop blood on FTA Card
- Pre‑Test Information: Clinical history of the patient; a genetic counselling session to draw a family pedigree chart of affected members for DSPP gene mutation analysis is strongly recommended.
- Facility License (MOHAP): 9834453
Appropriate Referring Specialists & Clinical Intent
Three high‑relevance specialists typically order this test:
- Clinical Geneticist (or Medical Geneticist) – to provide a definitive molecular diagnosis, evaluate inheritance pattern, and counsel families on recurrence risk.
- Dentist (Paediatric/General Dentist with expertise in dental anomalies) – to plan early restorative or orthodontic management, and correlate clinical findings with genetic results.
- Dermatologist – to screen for associated ectodermal/skin manifestations that co‑occur with dentinogenesis imperfecta in certain syndromes, ensuring holistic care.
Clinical Intent: Confirm diagnosis of dentinogenesis imperfecta Shields type 2, guide personalised treatment, and enable informed family planning.
Physician Insight & Safety Protocol
“As a clinical physician, I understand that receiving a genetic diagnosis for dentinogenesis imperfecta can be emotionally challenging, but this test provides the certainty you need for informed family planning and tailored dental care. Please remember that this result is a piece of the clinical puzzle, not a standalone verdict, and I strongly advise clinical correlation with a dentofacial specialist. Your well‑being remains our priority, and we are here to guide you every step of the way.”
— Dr. PRABHAKAR REDDY, DHA Licence 61713031
Medication Warning:
Do not discontinue any prescribed medication without consulting your doctor. Genetic test results are not a substitute for ongoing clinical management.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Not for emergency diagnostic purposes; not a stand‑alone prenatal test without comprehensive genetic counselling; not indicated for patients under 18 years without parental consent as per UAE CDS Law 2026 (Minors).
- ER Red Flags: If you or your child experiences sudden severe dental pain, odontogenic infection with facial swelling, traumatic tooth fracture, or locked jaw, seek immediate dental emergency care or visit the nearest Emergency Department.
UAE Regulatory & Quality Compliance
Legal Mandates: This service abides by Federal Decree‑Law No. 41 of 2024 (Art. 87) on genetic testing, CDS Law 2026 (Minors) for paediatric consent, and UAE PDPL for data privacy.
Accreditation: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) ensuring every step from cold‑chain logistics to data interpretation meets international quality standards.
Patient FAQ & Clinical Guidance
Q1: What is the DSPP gene test for?
Snippet‑Killer Answer (First Sentence): This robust Genetic Test accurately detects DSPP gene mutations causing dentinogenesis imperfecta Shields type 2, enabling definitive diagnosis and genetic counseling.
It analyses the entire coding region of the DSPP gene to identify pathogenic variants that explain clinical symptoms such as opalescent, weak teeth. The is used to confirm a suspected clinical diagnosis, differentiate from other dental genetic disorders, and provide crucial information for family risk assessment.
سؤال ١: ما هو اختبار جين DSPP؟
يكتشف اختبار الحمض النووي المتقدم هذا الطفرات الممرضة في جين DSPP المسؤولة عن عيب تكون العاج من النوع الثاني (شيلدز)، مما يتيح التشخيص القاطع والاستشارة الوراثية.
Q2: How is the sample collected?
Snippet‑Killer Answer (First Sentence): A blood sample, extracted DNA, or a single blood drop on an FTA card is collected conveniently at home by our VIP phlebotomy team, ensuring comfort.
Our certified phlebotomists arrive at your doorstep (8 AM–11 PM daily) with hospital‑grade safety gear and cold‑chain transport. For patients who have already purified DNA, we can also accept extracted DNA. The FTA card option is especially gentle for paediatric patients or those with needle anxiety.
سؤال ٢: كيف يتم جمع العينة؟
تُجمع عينة الدم، أو الحمض النووي المستخلص، أو قطرة دم واحدة على بطاقة FTA بسهولة في المنزل بواسطة فريق الفصد المتنقل VIP، مما يضمن الراحة التامة.
Q3: What does a positive result mean?
Snippet‑Killer Answer (First Sentence): A positive result indicates a disease‑causing DSPP variant, confirming dentinogenesis imperfecta Shields type 2 and guiding family risk assessment.
A positive finding means we have identified a genetic change known to cause the condition. This can help your dentist plan appropriate restorative treatments, inform orthodontic timing, and allow family members to consider cascade testing. A negative result, however, does not entirely rule out other genetic or environmental causes, and should be discussed with a genetic counsellor.
سؤال ٣: ماذا تعني النتيجة الإيجابية؟
تشير النتيجة الإيجابية إلى وجود متغير ممرض في جين DSPP، مما يؤكد تشخيص عيب تكون العاج من النوع الثاني (شيلدز) ويُرشد تقييم المخاطر العائلية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians